Liquid biopsies for management of pancreatic cancer.

@article{Samandari2018LiquidBF,
  title={Liquid biopsies for management of pancreatic cancer.},
  author={Mohamadmahdi Samandari and Mar{\'i}a Julia and Alistair Rice and Antonios Chronopoulos and Armando E Del R{\'i}o Hern{\'a}ndez},
  journal={Translational research : the journal of laboratory and clinical medicine},
  year={2018},
  volume={201},
  pages={
          98-127
        }
}
Pancreatic cancer is one of the main causes of cancer-related deaths worldwide. It is asymptomatic at an early stage, and most diagnosis occurs when the disease is already at a late stage, by which time the tumor is nonresectable. In order to increase the overall survival of patients with pancreatic cancer, as well as to decrease the cancer burden, it is necessary to perform early diagnosis, prognosis stratifications and cancer monitoring using accurate, minimally invasive, and cost-effective… CONTINUE READING
1
Twitter Mention

References

Publications referenced by this paper.
SHOWING 1-10 OF 276 REFERENCES

Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients.

  • Annals of oncology : official journal of the European Society for Medical Oncology
  • 2018
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

Detection of circulating tumor cells using negative enrichment immunofluorescence and an in situ hybridization system in pancreatic cancer

Y Xu
  • Int J Mol Sci 2017;18:622
  • 2017
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer

JS Ankeny
  • Br J Cancer
  • 2016
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

Circulating tumor cells (Ctc) and kras mutant circulating free DNA (cfDNA) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer

J Earl
  • BMC Cancer 2015;15:797
  • 2015
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL